Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

In dialogue with the NIH on clinical trials policy

In his capacity as immediate past president of the Federation of Associations of Behavioral and Brain Sciences, Jeremy Wolfe interviews Mike Lauer about the new NIH clinical trials policy. Mike Lauer is NIH’s deputy director for extramural research, serving as the principal scientific leader and advisor to the NIH director on the extramural research programme.

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Jeremy M. Wolfe.

Ethics declarations

Competing interests

J.M.W. is currently funded by the NIH. He does not have any current advisory role with the NIH though he has previously served as a grant reviewer and study section member. He has no involvement in setting the clinical trial policy changes or their implementation.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Wolfe, J.M. In dialogue with the NIH on clinical trials policy. Nat Hum Behav 2, 100–102 (2018).

Download citation

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing